Viewing Study NCT02684032


Ignite Creation Date: 2025-12-24 @ 9:49 PM
Ignite Modification Date: 2025-12-30 @ 6:18 AM
Study NCT ID: NCT02684032
Status: COMPLETED
Last Update Posted: 2022-07-27
First Post: 2016-02-10
Is NOT Gene Therapy: True
Has Adverse Events: False

Brief Title: A Study To Assess The Tolerability And Clinical Activity Of Gedatolisib In Combination With Palbociclib/Letrozole Or Palbociclib/Fulvestrant In Women With Metastatic Breast Cancer
Sponsor: Celcuity Inc
Organization:

Study Modules

Identification Module Status Module Sponsor Collaborators Module Oversight Module Description Module Conditions Module Design Module Arms Interventions Module Outcomes Module Eligibility Module Contacts Locations Module References Module